These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 5601004)

  • 1. [Lupus erythematosus of the tongue cured with nivaquine].
    Aguilera Maruri C; Aguilera Diaz L
    Actas Dermosifiliogr; 1967; 58(1):21-7. PubMed ID: 5601004
    [No Abstract]   [Full Text] [Related]  

  • 2. [Revaluation of the treatment of lupus erythematosus with nivaquine].
    Mercadal Peyrí JO
    Actas Dermosifiliogr; 1966; 57(5):143-50. PubMed ID: 5964335
    [No Abstract]   [Full Text] [Related]  

  • 3. [Resochin (aralen, nivaquine) in the treatment of lupus erythematosus & other skin diseases].
    POPOV L; POPKHRISPOV P; BOTEV ShT; BAZHDEKOV B; GRIGOROV I; KHLEBAROV S
    Suvr Med (Sofiia); 1958; 9(9):3-16. PubMed ID: 13615652
    [No Abstract]   [Full Text] [Related]  

  • 4. [Trial therapy of lupus erythematosus with local nivaquine punctures].
    CALAS E; CASTELAIN PY
    Lyon Med; 1958 Nov; 90(46):792. PubMed ID: 13612297
    [No Abstract]   [Full Text] [Related]  

  • 5. [On the effect of chloroquine phosphate on the glucocorticoid function of the adrenal cortex in patients with lupus erythematosus].
    Berezhnaia LA
    Vestn Dermatol Venerol; 1967 Jan; 41(1):27-8. PubMed ID: 5616446
    [No Abstract]   [Full Text] [Related]  

  • 6. [Neuropathy due to chloroquine in lupus erythematosus. 2 recent cases, emphasizing the necessity for ultrastructural study of the muscle biopsy].
    Godeau P; Herreman G; Himmich H; Godet-Guillain J; Chevallay M; Fardeau M
    Ann Med Interne (Paris); 1976 AUG-SEP; 127(8-9):544-51. PubMed ID: 1008378
    [No Abstract]   [Full Text] [Related]  

  • 7. The influence of antimalarial treatment on IL-1beta, IL-6 and TNF-alpha mRNA expression on UVB-irradiated skin in systemic lupus erythematosus.
    Wozniacka A; Lesiak A; Boncela J; Smolarczyk K; McCauliffe DP; Sysa-Jedrzejowska A
    Br J Dermatol; 2008 Nov; 159(5):1124-30. PubMed ID: 18764842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evolution and prognosis of lupus as a function of several criteria (sex, therapy, diagnosis, clinical form, pregnancy)].
    Geavlete A
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1981; 33(1):69-74. PubMed ID: 6114537
    [No Abstract]   [Full Text] [Related]  

  • 9. Diplopia in a patient under hydroxychloroquine for systemic lupus erythematosus.
    Sabbagh M
    Rev Rhum Engl Ed; 1997 Jan; 64(1):65. PubMed ID: 9051865
    [No Abstract]   [Full Text] [Related]  

  • 10. [Histomorphology and histochemistry of changes in the dermo-epidermal area in lupus erythematosus prior to and following treatment with chloroquine phosphate].
    Bajdekoff B; Hadjioloff AI; Zvetkova E; Velev N; Mintschev I
    Dermatol Monatsschr; 1973 Sep; 159(9):880-5. PubMed ID: 4770773
    [No Abstract]   [Full Text] [Related]  

  • 11. [Nivaquine therapy of lupus erythematosus].
    BURCKHARDT W
    Dermatologica; 1956; 112(4-6):560-1. PubMed ID: 13343925
    [No Abstract]   [Full Text] [Related]  

  • 12. [A case of disseminated lupus erythematosus treated with nivaquine for 16 months].
    ASCHKENASY A; LAYANI F; MARTEAU R
    Rev Rhum Mal Osteoartic; 1956 Jun; 23(6):523-7. PubMed ID: 13380174
    [No Abstract]   [Full Text] [Related]  

  • 13. [Maximal chloroquine dosage?].
    Korting GW
    Hautarzt; 1981 Aug; 32(8):438. PubMed ID: 7275580
    [No Abstract]   [Full Text] [Related]  

  • 14. Ovarian failure with thalidomide treatment in complex aphthosis: comment on the concise communication by Ordi et al.
    Gompel A; Frances C; Piette JC; Blanc AS; Cordoliani F; Piette AM
    Arthritis Rheum; 1999 Oct; 42(10):2259-60. PubMed ID: 10524707
    [No Abstract]   [Full Text] [Related]  

  • 15. [A case of acute systemic lupus erythematosus; resistance of the lupus nephropathy to combined treatment with prednisone, nivaquine and nitrogranulogen].
    DYK T
    Pol Arch Med Wewn; 1958; 28(3):363-75. PubMed ID: 13553978
    [No Abstract]   [Full Text] [Related]  

  • 16. [Some data on the functional efficiency of the kidney in lupus erythematosus].
    Cibirjaeva AD
    Dermatol Wochenschr; 1965 Jul; 151(30):870-3. PubMed ID: 5843005
    [No Abstract]   [Full Text] [Related]  

  • 17. [A case of acute systemic lupus erythematosus with extensive muscle atrophy; necessity of differentiation from dermatomyositis; positive effect of therapy with prednisone and nivaquine].
    DYK T
    Pol Arch Med Wewn; 1958; 28(3):353-61. PubMed ID: 13553977
    [No Abstract]   [Full Text] [Related]  

  • 18. Antimalarial drug-induced aquagenic-type pruritus in patients with lupus.
    Jiménez-Alonso J; Tercedor J; Jáimez L; García-Lora E
    Arthritis Rheum; 1998 Apr; 41(4):744-5. PubMed ID: 9550488
    [No Abstract]   [Full Text] [Related]  

  • 19. Systemic lupus erythematosus.
    Madhok R; Wu O
    Am Fam Physician; 2007 Nov; 76(9):1351-3. PubMed ID: 18019880
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of some dermatoses by the intradermal injections of a 10 percent solution of quingamine].
    Sharapova GIa; Khamaganova AV
    Sov Med; 1973 Jun; 36(6):149-50. PubMed ID: 4747420
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.